Table 3.
Adverse events (n,%) | |
Erythema | 234 (36.4%) |
Swelling | 159 (24.7%) |
Infection | 0 (0%) |
Skin necrosis | 3 (0.47%) |
Headache | 3 (0.47%) |
Patient satisfaction (0–10) | |
Mean (SD) | 7.4 (1.2) |
Additional treatment? (n, %) | 24 (3.7%) |
Treatment volume, mL (range) | (0.1–0.2 mL) |